\-\ Texto\\:\\ \ \(0\)\
\-\ general\\:\\ sleeping\\,\\ no\\ distress\ \(0\)\
\-\ heent\\:\\ fontanelles\\ flat\\,\\ dysmorphic\\ facies\\,\\ bilateral\\ cephalohematomas\\,\\ no\\ nasal\\ discharge\\,\\ red\\ reflex\\ present\\ bilaterally\\,\\ mmm\ \(0\)\
\-\ neck\\:\\ normal\\ range\\ of\\ motion\ \(0\)\
\-\ cardio\\:\\ \\ 2\\/6\\ systolic\\ ejection\\ murmur\\ at\\ the\\ left\\ sternal\\ edge\ \(0\)\
\-\ abdomen\\:\\ no\\ hepatosplenomegaly\ \(0\)\
\-\ neurologic\\:\\ arousable\\,\\ decreased\\ muscle\\ tone\ \(0\)\
\-\ skin\\:\\ warm\\,\\ mottling\\ is\\ present\\,\\ no\\ petechiae\\,\\ cyanosis\\,\\ jaundice\\,\\ or\\ pallor\\,\\ capillary\\ refill\\ less\\ than\\ 3\\ seconds\ \(0\)\
\-\ current\\ recommendations\\ state\\ that\\ antiviral\\ treatment\\ with\\ ganciclovir\\ and\\ valganciclovir\\ should\\ be\\ initiated\\ within\\ the\\ first\\ 30\\ days\\ of\\ life\\ only\\ in\\ newborns\\ with\\ severe\\ focal\\ organ\\ disease\\ or\\ cns\\ disease\\.\\ treatment\\ typically\\ lasts\\ for\\ 6\\ weeks\\.\\ \\ in\\ addition\\,\\ follow\\-up\\ audiological\\ and\\ ophthalmic\\ assessments\\ need\\ to\\ be\\ performed\\ on\\ all\\ newborns\\ with\\ confirmed\\ congenital\\ cmv\\ to\\ monitor\\ for\\ potential\\ neurological\\ sequelae\\.\ \(0\)\
\-\ periventricular\\ calcifications\ \(4\)\
\-\ cephalohematomas\\ over\\ the\\ parietal\\ skull\ \(0\)\
\-\ ventriculomegaly\\ with\\ layering\\ fluid\\ in\\ the\\ occipital\\ horns\ \(0\)\
\-\ hypoplastic\\ cerebellum\ \(0\)\
\-\ diffuse\\ white\\ matter\\ loss\\ with\\ sulcation\\ abnormality\ \(0\)\
\-\ congenital\\ cytomegalovirus\\ \\(cmv\\)\\ infection\ \(0\)\
\-\ cmv\\ \\(cytomegalovirus\\)\ \(0\)\
\-\ other\\ congenital\\ infections\\ such\\ as\\ rubella\\,\\ toxoplasmosis\\,\\ syphilis\\,\\ and\\ herpes\\ simplex\\ virus\ \(0\)\
\-\ leukoencephalopathy\ \(7\)\
\-\ metabolic\\ disorders\ \(2\)\
\-\ 8\\ day\\ bay\\ boy\\,\\ born\\ at\\ 34\\ weeks\\ via\\ vacuum\\ assisted\\ delivery\\ to\\ a\\ 24\\-year\\-old\\ g1p1\\ mother\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ \\-\\:\\ 0\\.07359623271596104\ \(0\)\
\-\ cmv\\:\\ 0\\.07343723991684768\ \(0\)\
\-\ cephalohematomas\\:\\ 0\\.07252117181612994\ \(0\)\
\-\ newborns\\:\\ 0\\.06133578816884986\ \(0\)\
\-\ cytomegalovirus\\:\\ 0\\.058151190455111176\ \(0\)\
\-\ congenital\\:\\ 0\\.04185480762913979\ \(0\)\
\-\ arousable\\:\\ 0\\.03935499296413615\ \(0\)\
\-\ ganciclovir\\:\\ 0\\.03935499296413615\ \(0\)\
\-\ valganciclovir\\:\\ 0\\.03935499296413615\ \(0\)\
\-\ mottling\\:\\ 0\\.03626058590806497\ \(0\)\
\-\ audiological\\:\\ 0\\.03626058590806497\ \(0\)\
\-\ \\:\\:\\ 0\\.03532108799970828\ \(0\)\
\-\ antiviral\\:\\ 0\\.03316617885199378\ \(0\)\
\-\ bay\\:\\ 0\\.03316617885199378\ \(0\)\
\-\ 24\\-year\\-old\\:\\ 0\\.03316617885199378\ \(0\)\
\-\ fontanelles\\:\\ 0\\.03217000228362677\ \(0\)\
\-\ cardio\\:\\ 0\\.03217000228362677\ \(0\)\
\-\ lasts\\:\\ 0\\.03135606676222519\ \(0\)\
\-\ assessments\\:\\ 0\\.03135606676222519\ \(0\)\
\-\ sulcation\\:\\ 0\\.03066789408442493\ \(0\)\
\-\ dysmorphic\\:\\ 0\\.030071771795922596\ \(0\)\
\-\ rubella\\:\\ 0\\.030071771795922596\ \(0\)\
\-\ petechiae\\:\\ 0\\.029545954672456597\ \(0\)\
\-\ g1p1\\:\\ 0\\.029545954672456597\ \(0\)\
\-\ mmm\\:\\ 0\\.029075595227555588\ \(0\)\
\-\ pallor\\:\\ 0\\.029075595227555588\ \(0\)\
\-\ vacuum\\:\\ 0\\.029075595227555588\ \(0\)\
\-\ facies\\:\\ 0\\.02865010335342914\ \(0\)\
\-\ 2\\/6\\:\\ 0\\.028261659706154005\ \(0\)\
\-\ simplex\\:\\ 0\\.028261659706154005\ \(0\)\
\-\ ventriculomegaly\\:\\ 0\\.02790432618975429\ \(0\)\
\-\ seconds\\:\\ 0\\.027265483137786997\ \(0\)\
\-\ refill\\:\\ 0\\.026451547616385417\ \(0\)\
\-\ leukoencephalopathy\\:\\ 0\\.026451547616385417\ \(0\)\
\-\ ophthalmic\\:\\ 0\\.025981188171484405\ \(0\)\
\-\ sleeping\\:\\ 0\\.025763374938585153\ \(0\)\
\-\ syphilis\\:\\ 0\\.025555696297357954\ \(0\)\
\-\ recommendations\\:\\ 0\\.02535725092873816\ \(0\)\
\-\ hepatosplenomegaly\\:\\ 0\\.025167252650082822\ \(0\)\
\-\ sternal\\:\\ 0\\.024985011603117398\ \(0\)\
\-\ virus\\:\\ 0\\.024985011603117398\ \(0\)\
\-\ ejection\\:\\ 0\\.024809919133683106\ \(0\)\
\-\ herpes\\:\\ 0\\.024641435526616826\ \(0\)\
\-\ assisted\\:\\ 0\\.024641435526616826\ \(0\)\
\-\ toxoplasmosis\\:\\ 0\\.02447907997228256\ \(0\)\
\-\ warm\\:\\ 0\\.024322422294553676\ \(0\)\
\-\ layering\\:\\ 0\\.024171076081715814\ \(0\)\
\-\ horns\\:\\ 0\\.024024692944113177\ \(0\)\
\-\ initiated\\:\\ 0\\.023482903403915553\ \(0\)\
\-\ jaundice\\:\\ 0\\.022776546237777633\ \(0\)\
\-\ sequelae\\:\\ 0\\.02266896788251397\ \(0\)\
\-\ capillary\\:\\ 0\\.02246128924128677\ \(0\)\
\-\ flat\\:\\ 0\\.022360963991947223\ \(0\)\
\-\ cyanosis\\:\\ 0\\.022360963991947223\ \(0\)\
\-\ organ\\:\\ 0\\.022360963991947223\ \(0\)\
\-\ hypoplastic\\:\\ 0\\.02207284559401164\ \(0\)\
\-\ periventricular\\:\\ 0\\.021980795204713712\ \(0\)\
\-\ \\,\\:\\ 0\\.021753487407639167\ \(0\)\
\-\ monitor\\:\\ 0\\.02171551207761192\ \(0\)\
\-\ weeks\\:\\ 0\\.021654265686617394\ \(0\)\
\-\ state\\:\\ 0\\.02154702847054564\ \(0\)\
\-\ edge\\:\\ 0\\.021384672916211378\ \(0\)\
\-\ tone\\:\\ 0\\.021384672916211378\ \(0\)\
\-\ systolic\\:\\ 0\\.021228015238482497\ \(0\)\
\-\ reflex\\:\\ 0\\.020788550627709044\ \(0\)\
\-\ red\\:\\ 0\\.019905399987843332\ \(0\)\
\-\ born\\:\\ 0\\.019905399987843332\ \(0\)\
\-\ murmur\\:\\ 0\\.01973691638077705\ \(0\)\
\-\ delivery\\:\\ 0\\.019574560826442784\ \(0\)\
\-\ cns\\:\\ 0\\.019521728426232954\ \(0\)\
\-\ need\\:\\ 0\\.019025185412348024\ \(0\)\
\-\ cerebellum\\:\\ 0\\.018978438537940456\ \(0\)\
\-\ 34\\:\\ 0\\.018932176095817477\ \(0\)\
\-\ nasal\\:\\ 0\\.018886388148642526\ \(0\)\
\-\ metabolic\\:\\ 0\\.018841065061749592\ \(0\)\
\-\ discharge\\:\\ 0\\.018494149953145498\ \(0\)\
\-\ heent\\:\\ 0\\.018452621414474457\ \(0\)\
\-\ potential\\:\\ 0\\.018370705616848577\ \(0\)\
\-\ disorders\\:\\ 0\\.018250583059170346\ \(0\)\
\-\ infections\\:\\ 0\\.01813360818241131\ \(0\)\
\-\ current\\:\\ 0\\.01787202709193786\ \(0\)\
\-\ occipital\\:\\ 0\\.01780002092260802\ \(0\)\
\-\ mother\\:\\ 0\\.01742349793852878\ \(0\)\
\-\ present\\:\\ 0\\.01723222101724715\ \(0\)\
\-\ life\\:\\ 0\\.016642509324705866\ \(0\)\
\-\ neurological\\:\\ 0\\.016506806301561355\ \(0\)\
\-\ via\\:\\ 0\\.016375106906933237\ \(0\)\
\-\ parietal\\:\\ 0\\.01629791272340618\ \(0\)\
\-\ skull\\:\\ 0\\.016247181658002985\ \(0\)\
\-\ addition\\:\\ 0\\.016172149879804854\ \(0\)\
\-\ general\\:\\ 0\\.01607402976052461\ \(0\)\
\-\ distress\\:\\ 0\\.01607402976052461\ \(0\)\
\-\ neurologic\\:\\ 0\\.015930778356276837\ \(0\)\
\-\ treatment\\:\\ 0\\.015443008567865062\ \(0\)\
\-\ no\\:\\ 0\\.01536507411971075\ \(0\)\
\-\ range\\:\\ 0\\.01535821435840327\ \(0\)\
\-\ motion\\:\\ 0\\.015337594064401957\ \(0\)\
\-\ matter\\:\\ 0\\.015019999867860703\ \(0\)\
\-\ 30\\:\\ 0\\.014670041680603013\ \(0\)\
\-\ skin\\:\\ 0\\.014652361318031151\ \(0\)\
\-\ confirmed\\:\\ 0\\.014345533942351774\ \(0\)\
\-\ 8\\:\\ 0\\.014263917670756018\ \(0\)\
\-\ calcifications\\:\\ 0\\.014183766761753359\ \(0\)\
\-\ abnormality\\:\\ 0\\.014073919392100679\ \(0\)\
\-\ muscle\\:\\ 0\\.013702300149224753\ \(0\)\
\-\ typically\\:\\ 0\\.013466186471008803\ \(0\)\
\-\ boy\\:\\ 0\\.012967507946098085\ \(0\)\
\-\ less\\:\\ 0\\.012919375019297689\ \(0\)\
\-\ first\\:\\ 0\\.01280126533386541\ \(0\)\
\-\ white\\:\\ 0\\.012652250949607221\ \(0\)\
\-\ bilaterally\\:\\ 0\\.012529934100553138\ \(0\)\
\-\ disease\\:\\ 0\\.012470870903711644\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.012410879426079205\ \(0\)\
\-\ should\\:\\ 0\\.012161645276289285\ \(0\)\
\-\ day\\:\\ 0\\.012111427809611292\ \(0\)\
\-\ such\\:\\ 0\\.011925592811789518\ \(0\)\
\-\ be\\:\\ 0\\.01176568502985651\ \(0\)\
\-\ severe\\:\\ 0\\.011737990178866089\ \(0\)\
\-\ days\\:\\ 0\\.01169229596505347\ \(0\)\
\-\ diffuse\\:\\ 0\\.011549140269532654\ \(0\)\
\-\ only\\:\\ 0\\.011470587761093462\ \(0\)\
\-\ 6\\:\\ 0\\.011393393577566403\ \(0\)\
\-\ decreased\\:\\ 0\\.011342662512163211\ \(0\)\
\-\ abdomen\\:\\ 0\\.011300822602212929\ \(0\)\
\-\ neck\\:\\ 0\\.011201978290261082\ \(0\)\
\-\ infection\\:\\ 0\\.011089359705682174\ \(0\)\
\-\ loss\\:\\ 0\\.01107350076994839\ \(0\)\
\-\ focal\\:\\ 0\\.010895060732760723\ \(0\)\
\-\ fluid\\:\\ 0\\.01084213885983863\ \(0\)\
\-\ all\\:\\ 0\\.010789837006389691\ \(0\)\
\-\ performed\\:\\ 0\\.010636510407264816\ \(0\)\
\-\ at\\:\\ 0\\.010337171007425294\ \(0\)\
\-\ than\\:\\ 0\\.009995753816599437\ \(0\)\
\-\ over\\:\\ 0\\.009712690134553404\ \(0\)\
\-\ bilateral\\:\\ 0\\.00925811486301091\ \(0\)\
\-\ or\\:\\ 0\\.008942167401461674\ \(0\)\
\-\ 3\\:\\ 0\\.008932926458511337\ \(0\)\
\-\ other\\:\\ 0\\.008793029235278789\ \(0\)\
\-\ within\\:\\ 0\\.0072773723588664355\ \(0\)\
\-\ that\\:\\ 0\\.006589199681066175\ \(0\)\
\-\ for\\:\\ 0\\.006509894184309956\ \(0\)\
\-\ \\(\\:\\ 0\\.006449658270034468\ \(0\)\
\-\ \\)\\:\\ 0\\.006370872251011652\ \(0\)\
\-\ normal\\:\\ 0\\.005980412743745987\ \(0\)\
\-\ as\\:\\ 0\\.005770435294170213\ \(0\)\
\-\ to\\:\\ 0\\.005719662166647137\ \(0\)\
\-\ in\\:\\ 0\\.005643712903664128\ \(0\)\
\-\ left\\:\\ 0\\.004268327094968369\ \(0\)\
\-\ on\\:\\ 0\\.003231656305202804\ \(0\)\
\-\ with\\:\\ 0\\.0026117003591493246\ \(0\)\
\-\ is\\:\\ 0\\.002510226689217525\ \(0\)\
\-\ the\\:\\ 0\\.0024687372268504607\ \(0\)\
\-\ and\\:\\ 0\\.002410834898199354\ \(0\)\
\-\ a\\:\\ 0\\.001770534829547327\ \(0\)\
\-\ of\\:\\ 0\\.0010402125071248965\ \(0\)\
\-\ \\.\\:\\ 0\\.000633920287452612\ \(0\)\
